Problem-Solving Therapy (PST): Protocol, Evidence Base, and Efficacy for Depression and Suicidality in Older Adults

Problem-Solving Therapy (PST) is a brief, structured psychotherapeutic intervention grounded in the social problem-solving model originally articulated by D'Zurilla and Goldfried in 1971 and subsequently refined by D'Zurilla and Nezu. PST operates on the premise that psychological distress—particularly depression—arises from or is exacerbated by ineffective coping with everyday problems. By systematically training individuals to identify problems, generate solutions, evaluate options, and implement action plans, PST directly targets the cognitive-behavioral deficits that maintain depressive episodes.

PST has garnered particular attention in geriatric psychiatry, where it has emerged as one of the most well-studied psychotherapies for late-life depression and suicidal ideation in older adults. Its structured, concrete format makes it especially well-suited for older adults who may have executive dysfunction, medical comorbidity, or limited prior exposure to psychotherapy. Unlike more abstract or insight-oriented modalities, PST provides a tangible skill set that patients can immediately apply to real-world stressors.

The therapy has been adapted for delivery in primary care, home-based settings, and via telehealth—making it one of the most versatile evidence-based treatments for depression across the lifespan. This article reviews PST's theoretical foundations, specific treatment protocol, efficacy data with quantitative outcomes, head-to-head comparisons, moderators of response, limitations, and clinical adaptations for special populations.

Psychological Mechanisms

PST is rooted in the social problem-solving model, which posits two overarching dimensions: (1) problem orientation—an individual's cognitive-emotional set toward problems, including appraisals of self-efficacy, perceived control, and emotional reactions; and (2) problem-solving style—the actual cognitive-behavioral strategies employed to manage problems, which may be rational, impulsive/careless, or avoidant.

Depression is associated with a negative problem orientation (NPO)—a tendency to perceive problems as threats, doubt one's ability to cope, and respond with frustration and hopelessness. Research by Nezu, Nezu, and D'Zurilla has consistently demonstrated that NPO is a stronger predictor of depressive symptoms than deficits in rational problem-solving skills per se. PST therefore targets both dimensions: shifting orientation from negative to positive and training systematic rational problem-solving skills.

The mechanism of change involves several interrelated processes: (a) increased self-efficacy as patients experience mastery in solving previously overwhelming problems; (b) behavioral activation inherent in implementing solutions; (c) cognitive restructuring of hopelessness appraisals ("nothing I do will help"); and (d) reduction in avoidance, a key maintaining factor for depression.

Neurobiological Mechanisms

PST engages and strengthens prefrontal executive functions—specifically dorsolateral prefrontal cortex (dlPFC) processes involved in planning, cognitive flexibility, and decision-making. Late-life depression is frequently characterized by executive dysfunction, with structural and functional abnormalities in fronto-striatal circuits. Neuroimaging studies indicate that white matter hyperintensities in frontal-subcortical pathways, common in vascular depression, are associated with impaired problem-solving ability and poorer treatment response to antidepressants.

PST may partially compensate for these deficits by providing an external scaffolding structure for problem-solving—essentially offloading executive demands onto worksheets and systematic steps. Alexopoulos and colleagues at Weill Cornell have proposed that PST functions as a "cognitive prosthetic" for patients with depression-executive dysfunction syndrome (DED), helping them engage planning and action-sequencing capacities that are functionally impaired. Functional MRI data suggest that successful problem-solving training can increase activation in the left dlPFC and reduce amygdala hyperreactivity, though direct neuroimaging studies of PST specifically remain limited.

From a neurochemical perspective, the behavioral activation component of PST is hypothesized to increase dopaminergic reward signaling in the mesolimbic pathway, while the reduction in perceived helplessness may attenuate hypothalamic-pituitary-adrenal (HPA) axis dysregulation—a hallmark of chronic depression.

Standard PST protocols typically involve 6 to 12 sessions, each lasting 45–60 minutes, delivered weekly or biweekly. The Nezu and Nezu manualized version (published in Problem-Solving Therapy: A Treatment Manual, Springer, 2013) provides the most widely used clinical framework. A briefer adaptation, PST for Primary Care (PST-PC), condenses the protocol to 4–6 sessions of approximately 30 minutes.

The Seven Steps of Problem-Solving

The core of PST involves training patients in a systematic sequence, often summarized as seven steps:

1. Problem identification and definition: The patient learns to specify the problem concretely, separating facts from assumptions and breaking complex situations into manageable components.
2. Goal setting: Establishing realistic, specific, and measurable goals for problem resolution.
3. Brainstorming (generation of alternatives): Producing as many potential solutions as possible without premature evaluation—applying the "quantity breeds quality" principle.
4. Decision-making (evaluating solutions): Systematically rating each solution on feasibility, likely consequences (short- and long-term), personal values alignment, and emotional impact.
5. Solution selection: Choosing the best solution or combination of solutions based on the evaluation.
6. Implementation: Developing a concrete, step-by-step action plan with timeline, needed resources, and anticipated obstacles.
7. Verification and evaluation: Reviewing the outcome, comparing it with the desired goal, and either reinforcing success or troubleshooting by cycling back through earlier steps.

Session-by-Session Overview

Sessions 1–2: Psychoeducation about the problem-solving model of depression; assessment of the patient's current problem-solving style (positive vs. negative orientation, rational vs. avoidant/impulsive style); introduction of the problem-solving worksheet; collaborative identification of a problem list ranked by priority and tractability.

Sessions 3–6: Guided practice through the seven steps using real problems from the patient's life. The therapist models the process, then progressively shifts to a coaching role as the patient gains competence. Homework involves applying the steps independently to identified problems. Worksheets serve as structured tools for between-session practice.

Sessions 7–10 (if extended protocol): Continued application to more complex or emotionally charged problems. Attention to relapse prevention—identifying early warning signs of returning to avoidant or impulsive problem-solving. Development of a "problem-solving toolkit" for future use.

Sessions 11–12 (or final sessions): Review of progress, consolidation of skills, planning for maintenance, and booster session scheduling if applicable.

Problem Orientation Training

A critical but sometimes underemphasized component is problem orientation training, which targets the emotional and motivational barriers to engaging in problem-solving. Techniques include cognitive restructuring of catastrophic appraisals ("This problem is impossible"), visualization exercises, and motivational interviewing elements. Research by Nezu and colleagues indicates that PST protocols that explicitly address problem orientation produce larger effect sizes than those focused solely on skills training.

Meta-Analytic Evidence

The most comprehensive meta-analysis of PST for depression was conducted by Cuijpers, de Wit, Kleiboer, Karyotaki, and Ebert (2018), published in Clinical Psychology Review. This analysis included 30 randomized controlled trials (RCTs) and found a pooled effect size of d = 0.37 (95% CI: 0.23–0.51) compared to control conditions (waitlist, care-as-usual, attention placebo). When restricted to comparisons with care-as-usual only, the effect size was somewhat larger (d ≈ 0.46). These are considered small to medium effects, broadly comparable to other evidence-based psychotherapies for depression.

An earlier meta-analysis by Bell and D'Zurilla (2009) in Clinical Psychology Review found a somewhat larger overall effect size of d = 0.34 for clinical depression and d = 0.83 for subclinical depression and distress, suggesting PST may be particularly potent for subthreshold depressive presentations. This finding has important implications for preventive interventions and stepped-care models.

Response and Remission Rates

Individual RCTs report depression response rates (typically defined as ≥50% reduction in Hamilton Depression Rating Scale [HAM-D] or PHQ-9 scores) ranging from 40% to 65% for PST, compared with 15–30% for usual care controls. Remission rates are less consistently reported but range from 25% to 45% in active treatment arms. In the IMPACT trial (Improving Mood–Promoting Access to Collaborative Treatment; Unützer et al., 2002), which used PST as one arm of a collaborative care model for late-life depression in primary care, 45% of intervention patients achieved ≥50% reduction in depressive symptoms at 12 months, compared with 19% in usual care—a clinically meaningful difference yielding a number needed to treat (NNT) of approximately 4.

Comparisons with Other Psychotherapies

Head-to-head comparisons between PST and other active treatments show mixed but generally equivalent outcomes:

• PST vs. Cognitive-Behavioral Therapy (CBT): The Cuijpers et al. (2018) meta-analysis found no statistically significant difference between PST and CBT when directly compared (relative effect size near zero). Both therapies share behavioral activation and cognitive components, and PST can be conceptualized as a focused form of CBT.
• PST vs. Pharmacotherapy: In the PROSPECT trial (Prevention of Suicide in Primary Care Elderly: Collaborative Trial; Bruce et al., 2004), patients receiving clinical management with citalopram or PST (offered based on preference) showed significantly greater resolution of suicidal ideation and depressive symptoms compared with usual care. Specific effect sizes for PST alone versus medication alone were not cleanly separable in PROSPECT's design, but post-hoc analyses suggested comparable effects for both modalities.
• PST vs. Behavioral Activation (BA): Limited direct comparisons exist. Both share emphasis on activity engagement and reduction of avoidance. Theoretical analyses suggest PST provides more structured cognitive scaffolding, while BA focuses more on value-driven activity scheduling.

Durability of Effects

Follow-up data suggest PST's benefits are maintained at 6–12 months post-treatment, with some studies showing continued improvement beyond treatment termination as patients apply learned skills. In the IMPACT trial, treatment gains were sustained at 24-month follow-up. Relapse prevention data specific to PST are limited but consistent with the broader psychotherapy literature showing that skills-based treatments confer longer-lasting protection than pharmacotherapy alone.

The PROSPECT Trial

The landmark evidence for PST's role in reducing suicidality in older adults comes from the PROSPECT trial (Bruce et al., 2004; Alexopoulos et al., 2009), a multisite RCT conducted across 20 primary care practices in New York, Philadelphia, and Pittsburgh. PROSPECT tested a collaborative care intervention in which depression care managers offered either citalopram or PST (based on patient preference and clinical judgment) to adults aged 60 and older with major or minor depression.

Key findings from PROSPECT:

• At 12 months, intervention patients showed 2.2 times greater odds of resolution of suicidal ideation compared with usual care (OR = 2.2, 95% CI: 1.2–4.0).
• Among patients with major depression, the intervention group had significantly greater decline in Hamilton Depression Rating Scale scores (mean difference ≈ 3.5 points).
• The effect on suicidal ideation was especially pronounced: 71% of intervention patients with baseline suicidal ideation had resolution by 12 months, compared with 44% in usual care.
• At 24-month follow-up, mortality differences emerged: intervention patients had significantly lower all-cause mortality, a finding attributed partly to reduction in depression severity and suicide risk.

The IMPACT Trial and Late-Life Depression

The IMPACT trial (Unützer et al., 2002)—the largest RCT of collaborative care for late-life depression—enrolled 1,801 adults aged 60+ across 18 primary care clinics. PST was offered as the psychotherapy component alongside antidepressant management. At 12 months, 45% of IMPACT intervention patients had ≥50% reduction in SCL-20 depression scores, versus 19% in usual care. The intervention was also associated with significant improvements in functional disability, quality of life, and self-efficacy. IMPACT's NNT of approximately 4 for treatment response represents strong clinical significance.

Mechanisms Relevant to Suicidality

PST's efficacy for suicidal ideation likely operates through multiple pathways beyond depression reduction. Hopelessness—a stronger predictor of suicide than depression severity per se (Beck et al., 1985)—is directly targeted by PST's emphasis on generating actionable solutions. The therapy counters the cognitive narrowing characteristic of suicidal crisis ("tunnel vision") by systematically expanding the perceived solution space. Additionally, impaired problem-solving has been identified as a trait-like vulnerability marker for suicidal behavior independent of depression (Pollock & Williams, 2004), suggesting PST addresses a proximal risk factor.

Home-Based PST (PST-HC)

Recognizing that many older adults with depression are homebound or have mobility limitations, Alexopoulos, Raue, and colleagues developed and tested Problem-Solving Therapy for Home Care (PST-HC), delivered by home-visiting nurses. In a pilot RCT, PST-HC produced significantly greater reduction in depression severity (PHQ-9) compared with usual home care, with a Cohen's d of approximately 0.56—a medium effect. This adaptation demonstrated feasibility and efficacy for a particularly vulnerable population often excluded from clinic-based research.

Understanding who benefits most from PST—and who may not—is critical for treatment matching and stepped-care decision-making.

Positive Predictors of Response

• Executive dysfunction: Counterintuitively, older adults with mild to moderate executive dysfunction may derive particular benefit from PST, because the structured external scaffolding compensates for impaired internal planning capacity. Alexopoulos et al. (2003) found that patients with the depression-executive dysfunction (DED) syndrome responded well to PST when the protocol included explicit compensatory strategies.
• Identifiable, solvable problems: Patients whose depression is maintained by specific, tractable psychosocial stressors (financial difficulties, caregiving burden, social isolation, medical treatment adherence) tend to benefit more than those with more diffuse, characterological issues.
• Subclinical depression: As noted in the Bell and D'Zurilla (2009) meta-analysis, effect sizes are larger for subthreshold depression and psychological distress (d = 0.83) than for major depressive disorder (d = 0.34), suggesting PST is an excellent preventive or early intervention strategy.
• Treatment preference concordance: Patients who prefer structured, skills-based approaches over exploratory or insight-oriented therapy show better engagement and outcomes with PST.

Negative Predictors and Potential Contraindications

• Severe executive dysfunction or moderate-severe dementia: While mild impairment may be compensated, patients with severe cognitive impairment cannot meaningfully engage in the multi-step problem-solving process, even with adaptations. Mini-Mental State Examination (MMSE) scores below approximately 20 are generally considered a threshold below which standard PST becomes unfeasible.
• Severe, recurrent major depression with melancholic features: Patients whose depression is predominantly driven by neurovegetative and endogenous processes, with less contribution from psychosocial stressors, may respond less to PST as a standalone treatment and may require combined pharmacotherapy.
• High negative problem orientation with low motivation: Patients with deeply entrenched hopelessness or pervasive avoidance may struggle to engage in PST's action-oriented framework without preliminary motivational enhancement or adjunctive treatment.
• Personality pathology: While limited data exist, severe personality disorders—particularly those characterized by interpersonal chaos and emotional dysregulation—may require more comprehensive treatment approaches (e.g., DBT) rather than problem-focused PST.

Demographic Moderators

Meta-analytic findings indicate that PST is effective across gender, race, and socioeconomic groups. However, treatment effects may be moderated by health literacy and educational attainment, as the structured worksheets require basic reading and writing ability. Adaptations using visual aids and oral delivery have addressed this barrier in some populations. Cultural adaptation studies have shown PST to be effective in Chinese, Korean, and Latino older adult populations when problem definitions and solution options are culturally contextualized.

Strongest Evidence

• Late-life depression in primary care: This is PST's strongest evidence base, anchored by the IMPACT and PROSPECT trials. PST is recommended as a first-line psychotherapy for late-life depression in multiple clinical guidelines including the APA Practice Guidelines and the NICE guidelines for depression in adults with chronic physical health problems.
• Depression with medical comorbidity: PST has demonstrated efficacy for depression in patients with diabetes (d ≈ 0.34–0.50 in multiple RCTs), cancer (d ≈ 0.30–0.45), heart failure, stroke, and traumatic brain injury. Its concrete, problem-focused approach maps well onto the practical challenges of chronic disease management.
• Subthreshold depression and distress: As a preventive intervention, PST shows large effects (d ≈ 0.83 per Bell & D'Zurilla) for preventing progression to major depression.
• Suicidal ideation in older adults: Supported by PROSPECT and related trials.

Moderate Evidence

• Adult major depression (non-elderly): Effective but with smaller effect sizes than for late-life depression, and less differentiation from other psychotherapies.
• Caregiver distress: Several RCTs show PST reduces depression and burden in family caregivers of individuals with dementia or chronic illness.
• Adjustment disorders and life transitions: PST is well-suited for time-limited stressors requiring adaptive coping.

Limited or Insufficient Evidence

• Generalized anxiety disorder: Some preliminary support, but the evidence base is thin compared to CBT.
• PTSD: PST is not considered a first-line PTSD treatment. Trauma-focused therapies (CPT, PE, EMDR) have superior evidence.
• Obsessive-compulsive disorder: No meaningful evidence supports PST for OCD; exposure and response prevention (ERP) remains the treatment of choice.
• Bipolar depression: PST has not been adequately studied in bipolar disorder and should not be assumed to generalize from unipolar depression findings.
• Psychotic depression: Active psychosis is generally a contraindication for standalone PST due to impaired reality testing and cognitive disorganization.

Adverse Effects

As a psychotherapy, PST does not carry pharmacological side effects. However, clinicians should be aware of potential therapeutic adverse effects:

• Frustration and demoralization: Patients who cannot successfully implement solutions—particularly those facing genuinely unsolvable problems (e.g., terminal illness, irreversible losses)—may experience increased frustration if the therapy is perceived as invalidating their grief or oversimplifying their situation.
• Problem-solving fatigue: The structured worksheet format can feel mechanical or tedious for some patients, potentially reducing engagement. Skilled therapists modulate the level of structure based on patient preference and cognitive capacity.
• Avoidance of emotional processing: PST's action orientation may inadvertently allow patients to avoid processing grief, trauma, or complex emotions that require more exploratory therapeutic approaches. This is a recognized limitation when depression is complicated by unresolved loss or relational trauma.

Key Limitations

• Effect sizes are modest for major depression: The pooled d = 0.37 from the Cuijpers et al. (2018) meta-analysis, while clinically meaningful, is at the lower end of psychotherapy effect sizes for depression. This suggests PST is best positioned as one component of a comprehensive treatment approach, particularly for moderate to severe depression.
• Publication bias concerns: The Cuijpers meta-analysis noted some evidence of publication bias, suggesting the true effect size may be slightly smaller than reported.
• Therapist competence variability: PST's apparent simplicity can lead to superficial delivery. Effective PST requires competent attention to problem orientation, motivational barriers, and individualized problem formulation—not merely rote worksheet completion.
• Limited utility for unsolvable problems: When primary stressors are genuinely intractable (e.g., chronic pain, progressive dementia in a spouse, poverty), PST must pivot toward emotion-focused coping strategies and acceptance-based approaches. Some PST protocols now incorporate this distinction between changeable and unchangeable problems.

Older Adults

The strongest adaptations exist for older adults, as detailed throughout this article. Key modifications include:

• Larger print materials and simplified worksheets
• Slower pacing with more repetition and review
• Integration of caregivers or family members when appropriate
• Home-based or telehealth delivery to address mobility barriers
• Explicit attention to age-specific problems: bereavement, medical illness, functional decline, social isolation, retirement adjustment
• Coordination with primary care for medical comorbidity management

PST for executive dysfunction: The adaptation by Alexopoulos and colleagues explicitly provides compensatory strategies—environmental cues, calendars, simplified decision matrices—for patients with frontal-subcortical impairment.

Children and Adolescents

PST has been adapted for youth populations, though the evidence base is smaller. Adaptations include:

• Developmentally appropriate language and examples
• Use of games, role-playing, and visual aids rather than written worksheets
• Involvement of parents/caregivers in problem-solving training
• Integration with school-based settings

A meta-analysis by Malouff, Thorsteinsson, and Schutte (2007) included some youth studies and found PST effective for reducing psychological distress, but specific pediatric depression RCTs are limited. PST components are embedded in several evidence-based youth treatments (e.g., the FRIENDS program, some school-based CBT protocols) without being identified as standalone PST.

Perinatal Depression

PST has been studied for perinatal depression, with promising results. A notable RCT by Grote et al. (2009) compared culturally adapted brief interpersonal psychotherapy with a PST-informed component for low-income pregnant women. Results showed significant depression reduction. PST's appeal for perinatal populations includes its time-limited format compatible with pregnancy and early postpartum timelines, its non-pharmacological nature (important for patients preferring to avoid medication during pregnancy/breastfeeding), and its ability to target practical stressors (financial strain, childcare logistics, relationship changes).

Culturally Diverse Populations

PST has been successfully culturally adapted for Chinese American, Korean American, and Latino older adults. Adaptations include language-concordant delivery, culturally relevant problem examples, incorporation of family decision-making norms, and attention to culturally specific barriers such as stigma around mental health treatment. Choi and colleagues demonstrated the feasibility and efficacy of PST delivered via telehealth to low-income, homebound older adults from diverse backgrounds.

Training Requirements

PST can be delivered by a range of professionals, which is one of its major implementation advantages:

• Licensed psychologists and psychiatrists: Typically require brief supplementary training (1–2 day workshops) given their existing psychotherapy competencies.
• Licensed clinical social workers and counselors: Similar brief training with supervised case experience.
• Primary care-embedded providers: PST-PC was specifically designed for delivery by non-specialist providers (nurse practitioners, physician assistants, care managers) in primary care settings, typically requiring 2–3 days of training plus ongoing supervision.
• Lay health workers and community health workers: Task-shifted PST models have been tested in low- and middle-income countries (e.g., the WHO's Problem Management Plus [PM+] program) with promising results. PM+ is a 5-session version deliverable by trained lay providers.

The relatively brief training period and manualized format make PST one of the most scalable evidence-based psychotherapies available. Key training resources include:

• The Treatment Innovation in Problem Solving (TIPS) online training program developed at the University of Washington
• Nezu, Nezu, and D'Zurilla's treatment manual (Problem-Solving Therapy: A Treatment Manual, Springer, 2013)
• The WHO PM+ training curriculum for global health implementation

Cost and Cost-Effectiveness

PST's brief format (6–12 sessions) makes it less costly than longer-term psychotherapies. Cost-effectiveness analyses from the IMPACT trial demonstrated that the collaborative care model (including PST) produced 107 additional depression-free days over 24 months at an incremental cost of approximately $580 per patient—well within accepted cost-effectiveness thresholds. The per-session cost is comparable to other individual psychotherapies and depends on provider credentials and setting (estimated $100–$250 per session in the U.S. for licensed provider delivery, substantially less when delivered by non-specialist staff in collaborative care models).

Insurance and Accessibility

PST is covered by most insurance plans under standard psychotherapy CPT codes (90834, 90837). It is recognized as an evidence-based treatment by the Substance Abuse and Mental Health Services Administration (SAMHSA) National Registry of Evidence-Based Programs and Practices (NREPP) and the VA/DoD Clinical Practice Guidelines for depression. However, patient access remains variable, with particular gaps in rural areas and among populations unfamiliar with or resistant to mental health treatment—contexts where PST's home-based and telehealth adaptations offer significant advantages.

The following trials represent the foundational evidence base for PST:

• IMPACT Trial (Unützer et al., 2002): The largest and most influential RCT of collaborative care for late-life depression. Enrolled 1,801 adults aged 60+ across 18 primary care clinics. Demonstrated that PST-based collaborative care produced response rates of 45% vs. 19% in usual care (NNT ≈ 4). Effects sustained at 24 months. Published in JAMA.
• PROSPECT Trial (Bruce et al., 2004; Alexopoulos et al., 2009): Multisite RCT of collaborative care (PST and/or citalopram) for depressed older adults in primary care. Demonstrated 2.2-fold greater odds of suicidal ideation resolution with intervention. Showed mortality benefit at extended follow-up. Published in JAMA and American Journal of Psychiatry.
• Areán et al. (2010) — PST vs. Supportive Therapy for Late-Life Depression: Compared PST to supportive therapy in older adults, with particular attention to executive function as a moderator. Found that patients with better executive function responded comparably to both treatments, while those with executive dysfunction responded significantly better to PST than to supportive therapy. Published in American Journal of Psychiatry.
• Mynors-Wallis et al. (2000): A UK-based RCT comparing PST delivered by GPs, PST delivered by practice nurses, antidepressant medication, and combined treatment for major depression in primary care. Found PST equivalent to antidepressants at 12 weeks (both superior to placebo), demonstrating PST's viability as a primary care intervention and its non-inferiority to medication. Published in BMJ.
• Choi et al. (2014): Tested telehealth-delivered PST (tele-PST) for homebound, low-income older adults with depression. Demonstrated feasibility, acceptability, and significant depression reduction compared to telephone support. Published in American Journal of Geriatric Psychiatry.
• Cuijpers et al. (2018) Meta-Analysis: The definitive meta-analysis of 30 RCTs yielding a pooled effect size of d = 0.37 for PST vs. controls. Identified no significant difference between PST and other active psychotherapies. Published in Clinical Psychology Review.

Based on the evidence reviewed, several clinical recommendations emerge:

• PST should be considered a first-line psychotherapy for late-life depression, particularly when delivered in collaborative care models. The IMPACT and PROSPECT evidence is robust and generalizable.
• PST is an appropriate monotherapy for mild to moderate depression and an effective adjunct to pharmacotherapy for moderate to severe depression. For severe depression, combined treatment is preferred.
• For older adults with suicidal ideation, PST should be strongly considered given the PROSPECT evidence demonstrating specific effects on ideation resolution.
• PST is well-suited for patients with medical comorbidity, where practical problem-solving around health management, treatment adherence, and functional adaptation is directly relevant to depression maintenance.
• Assessment of executive function should inform treatment selection: patients with executive dysfunction may particularly benefit from PST over less structured approaches.

Emerging Research Directions

Several promising research directions are advancing the field:

• Digital PST delivery: Smartphone apps and computer-assisted PST programs (e.g., the Beating the Blues platform incorporating PST elements) are being tested for scalability. Preliminary data suggest digital PST can produce small to medium effects (d ≈ 0.20–0.40) for depression.
• Integration with neurostimulation: Early-stage research is exploring PST combined with transcranial direct current stimulation (tDCS) targeting the dlPFC, hypothesizing synergistic effects on executive function and depression.
• Global mental health implementation: The WHO's PM+ program is demonstrating PST-derived interventions can be effectively task-shifted to lay providers in conflict-affected and resource-limited settings, with RCTs in Pakistan, Kenya, and Nepal showing meaningful symptom reduction.
• Precision treatment matching: Ongoing work aims to develop algorithms predicting which patients will respond preferentially to PST versus other psychotherapies, incorporating neuroimaging, executive function testing, and symptom profile data.